Nitrazepam for Severe Insomnia in Adults
Nitrazepam 2.5–5 mg at bedtime is effective for severe insomnia in adults, but doses should not exceed 5 mg—particularly in elderly patients—due to a 2–3 fold increased sensitivity to benzodiazepines and a dose-dependent risk of CNS depression, falls, and cognitive impairment. 1, 2
Recommended Dosing
Adults (Under 65 Years)
- Standard dose: 5 mg at bedtime for sleep induction and maintenance 3, 2
- Nitrazepam demonstrates efficacy in reducing sleep latency and improving sleep quality at this dose 3
Elderly Patients (≥65 Years)
- Maximum dose: 2.5–5 mg at bedtime—do not exceed 5 mg 1, 2
- Preferred starting dose: 2.5 mg in frail elderly, those with dementia, or patients on rehabilitation/long-stay wards 1
- Elderly patients show 2–3 fold greater benzodiazepine sensitivity due to post-receptor mechanism changes, not explained by altered pharmacokinetics alone 1
- At doses ≥10 mg, 55% of patients aged ≥80 years experience unwanted CNS depression 2
Critical Dosing Caveat
- Avoid 10 mg doses in elderly patients: A comparative study found that 10 mg nitrazepam caused severe hangover effects requiring treatment discontinuation in 15 of 68 elderly patients (22%), versus only 3 discontinuations with chlormethiazole 4
- Even 5 mg nitrazepam produces measurable psychomotor impairment the morning after dosing in approximately 50% of elderly inpatients, particularly those with mild dementia 1
Treatment Duration
- Short-term use (≤4 weeks) is recommended for benzodiazepines including nitrazepam 5
- Longer-term treatment may be considered in select cases after weighing risks versus benefits, though this is not the preferred approach 5
- Tapering is required when discontinuing: Benzodiazepine hypnotics should be gradually reduced while providing cognitive behavioral therapy for insomnia (CBT-I) to prevent withdrawal and rebound insomnia 6
Contraindications and Precautions
High-Risk Populations
- Elderly patients with dementia or low albumin: These patients show disproportionate sedation with regular dosing 1
- Patients with chronic renal failure: Increased risk of drug accumulation and adverse effects 1
- Individuals with intellectual disability: Benzodiazepines show higher rates of paradoxical responses, treatment resistance, and adverse effects in this population 7
Common Adverse Effects (Dose-Dependent)
- CNS depression (drowsiness, hangover): Reported in 2.3% overall, but 11% in patients ≥80 years 2
- Falls and fractures: Risk increases 3-fold with benzodiazepine use 8
- Cognitive impairment: Memory loss, confusion, and disorientation increase 5-fold in older patients 8
- Motor vehicle accidents: Risk increases with hypnotic use 8
- CNS stimulation (nightmares, agitation): Reported in 0.7% of patients, not age-related 2
Serious but Rare Harms
- Observational studies and FDA data suggest associations between hypnotics and increased all-cause mortality, though confounding cannot be excluded 8
- Tolerance and dependence can develop with continued use 8
Clinical Algorithm for Use
- First-line treatment should be CBT-I, not pharmacotherapy 5
- If pharmacotherapy is needed:
- In adults <65 years: Start nitrazepam 5 mg at bedtime
- In elderly ≥65 years: Start 2.5 mg, maximum 5 mg
- In frail elderly or those with dementia: Do not exceed 2.5 mg 1
- Limit duration to ≤4 weeks whenever possible 5
- Monitor for: Morning sedation, falls, cognitive changes, paradoxical agitation
- When discontinuing: Taper gradually while initiating CBT-I 6
Important Pitfall to Avoid
The most common prescribing error is using 10 mg doses in elderly patients, which produces unacceptable rates of hangover, falls, and cognitive impairment 4, 2. Modern guidelines favor newer agents (eszopiclone, zolpidem, suvorexant, dual orexin receptor antagonists) over traditional benzodiazepines like nitrazepam for chronic insomnia, particularly in older adults 8, 9, 10, 5.